Ahmed Abdeen Hamed

Dr. Ahmed Abdeen Hamed is a former Assistant Professor of Data Science and Artificial Intelligence at Norwich University and a former Research Team Leader in Clinical Data Science. He holds a Ph.D. from the University of Vermont (2014) and has extensive industry experience in pharmaceutical research. His work focuses on computational methods for drug discovery, network analysis, and AI-driven healthcare solutions, particularly in drug repurposing for diseases like COVID-19. He has developed algorithms such as MolecRank and NeoNet, and holds a patent for specificity-based molecule ranking systems.

Education: PhD in Data Science (University of Vermont, 2014).

Research Interests: Network-based drug discovery, biomedical informatics, AI in healthcare, clinical data science, and combating misinformation using machine learning. His recent work emphasizes leveraging clinical trials and biomedical literature to predict treatment efficacies through computational frameworks.

Key Contributions: First inventor on a molecule ranking patent (2021), co-developer of the CovidX algorithm for drug repurposing, and supervisor of PhD students/postdoctoral fellows. Collaborates with Sano teams to advance clinical research through AI.

• Awards: FastCompany Most Creative (2016)
• Industry Impact: Contributed to a multi-million dollar grant for a recommendation engine startup.

Labs/Teams: Currently part of Sano's research teams, focusing on computational clinical research and interdisciplinary collaborations.